We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)’s share was trading at $64.49 as of ...

Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, nearly doubled annual income and investment ...

Novo Holdings is a life sciences investment powerhouse that manages assets for the Novo Nordisk Foundation, one of the world's biggest philanthropic bodies. "2024 was a very strong year for Novo ...

Americans are running out of time to claim a $1,400 stimulus check. Tuesday marks Tax Day as well as the three-year deadline ...

Max Thieriot plays Bode Donovan, a former inmate navigating a new life as a firefighter in season 3 of the CBS drama, "Fire ...

India's obesity crisis is intensifying, with big pharma companies like Eli Lilly and Novo Nordisk competing to introduce ...

Kailera jumped the weight loss miracle-drug line by licensing four clinical-stage obesity therapies from China, which is ...

Lately, however, Eli Lilly's stock has cooled. Shares have been essentially flat since July 2024. The market for GLP-1 agonists could be evolving, and Eli Lilly has a high-stakes opportunity to ...

Explore how innovation, R&D, and policy reforms are reshaping China’s pharmaceutical sector amid rising healthcare demand and demographic shifts.

Dividend stocks have been a reliable cornerstone for those who want to anchor their portfolios when markets get shaky. These ...

Sparrow Quantum, a leading European supplier of photonic quantum chips, has secured €21.5 million in Series A funding to ...

Pharmaceutical powerhouse Eli Lilly (NYSE ... sleep apnea and reduce the risk of cardiovascular disease. Today, Novo Nordisk and Eli Lilly dominate the GLP-1 agonist market.